Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:53.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-13T13:37:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Version bump from v3.4.0 to v3.4.1. No visible changes to the study details page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:21.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive study information appears to be modified.
    Difference
    0.0%
    Check dated 2026-01-15T05:00:54.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now includes an administrative update showing the last known status with sponsor RemeGen Co., Ltd.; date 2023-12; verification status 'Verified'; and 'Unknown status'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-12-31T23:50:09.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added Beijing Municipality as a study location under Locations. Removed the HHS Vulnerability Disclosure and the Beijing Municipality Locations entry; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-17T18:42:07.000Z thumbnail image

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.